½ÃÀ庸°í¼­
»óǰÄÚµå
1587857

Àå·ç °ü¸® ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : Á¦Ç°º°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2030³â)

Stoma Care Market Size, Share & Trends Analysis Report By Product (Closed Bags, Open/Drainable Bags, One-piece Bags. Two-piece Bags), By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 100 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Àå·ç °ü¸® ½ÃÀå ¼ºÀå°ú µ¿Çâ:

Grand View ResearchÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é, ¼¼°è Àå·ç °ü¸® ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 8¾ï 7,320¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ ½ÃÀåÀº 2025³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 6.4%ÀÇ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ´ëÀå¾Ï, ¿°Áõ¼º ÀåÁúȯ(IBD) ȯÀÚ Áõ°¡, ÷´Ü ±â¼ú äÅà Áõ°¡, Àå·ç °ü¸® Á¦Ç°¿¡ ´ëÇÑ ÀÎ½Ä °³¼±ÀÌ ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ¿äÀÎÀ¸·Î ²ÅÈü´Ï´Ù.

´ëÀå¾ÏÀº Àå·çÀÇ °¡Àå ÈçÇÑ ¿øÀÎÀ¸·Î Àüü »ç·ÊÀÇ ¾à 45.6%¸¦ Â÷ÁöÇÕ´Ï´Ù. ÀΰøÇ×¹® ¼ö¼úÀÇ 45.0% ÀÌ»óÀÌ 60¼¼ ÀÌ»óÀÇ Àå·ç ȯÀÚ¿¡°Ô ½ÃÇàµÇ°í ÀÖ¾î ÇコÄɾî Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ´ëÀå¾ÏÀº ³²³à ¸ðµÎ¿¡¼­ ¼¼ ¹øÂ°·Î ¸¹Àº ¾ÏÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, ¼¼°èº¸°Ç±â±¸(WHO)°¡ ¹ßÇ¥ÇÑ º¸°í¼­¿¡ µû¸£¸é 2020³â ´ëÀå¾ÏÀ¸·Î ÀÎÇÑ 193¸¸ °ÇÀÇ »ç·Ê Áß 935¸¸5000¸íÀÌ »ç¸ÁÇÑ °ÍÀ¸·Î º¸°íµÆ½À´Ï´Ù. ´ëÀå¾ÏÀº 50¼¼ ÀÌ»ó ¼ºÀο¡°Ô ¸¹ÀÌ ¹ß»ýÇÏÁö¸¸, 50¼¼ ¹Ì¸¸ÀÇ ¹ßº´·üÀº ¸Å³â 2.2%¾¿ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¿¹¸¦ µé¾î, ¹Ì±¹ ¾ÏÇùȸ¿¡ µû¸£¸é 2020³â¿¡´Â ¾à 1.4¹é¸¸ ¸íÀÌ ´ëÀå¾Ï Áø´ÜÀ» ¹ÞÀ» °ÍÀ¸·Î ¿¹»óµÇ¸ç, ±× Áß 12.00%´Â 50¼¼ ¹Ì¸¸ÀÔ´Ï´Ù. ¶ÇÇÑ ±¹¸³»ý¹°°øÇÐÁ¤º¸¼¾ÅÍ(NCBI)¿¡ µû¸£¸é ´ëÀå¾ÏÀº ¾Æ¶ø¿¡¹Ì¸®Æ® ³²¼ºÀÇ »ç¸Á·üÀÌ °¡Àå ³ô°í, ÀϺ»¿¡¼­´Â ¿©¼ºÀÇ »ç¸Á·üÀÌ °¡Àå ³ôÀº °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. µû¶ó¼­ ÀÌ·¯ÇÑ »ç·Ê´Â ÀÌ·¯ÇÑ »ç·ÊÀÇ Ä¡·á¿¡ ÇʼöÀûÀÎ ¿ä±¸ »çÇ× Áß Çϳª ÀÎ °Ç°­ °ü¸® Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä°¡ Å©°Ô Áõ°¡ÇÏ¿© ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

Àå·ç °ü¸® ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

  • ¼öÀÍ Ãø¸é¿¡¼­´Â ±âŸ ºÎ¹®ÀÌ 2024³â °¡Àå Å« ¼öÀÍ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. Àü ¼¼°èÀûÀ¸·Î Àå·çÀÇ ¼ö°¡ Áõ°¡Çϰí ÀÖ´Â °ÍÀÌ ÀÌ ºÎ¹®ÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù.
  • Àΰø Ç×¹® ºÎ¹®Àº 2024³â °¡Àå Å« ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇßÀ¸¸ç, ´ëÀå¾Ï À¯º´·ü Áõ°¡·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È »ó´çÇÑ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
  • 2024³â, ÀçÅà °£È£ ¼³Á¤ ºÎ¹®ÀÌ °¡Àå Å« ¼öÀÍ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ÀÌ ºÎ¹®ÀÇ ¼ºÀåÀº Àü ¼¼°èÀûÀ¸·Î COVID-19°¡ ¹ß»ýÇϸ鼭 ȯÀÚµéÀÌ ÀçÅà °£È£ ¼­ºñ½º¸¦ ¼±ÅÃÇÏ´Â °ÍÀÌ ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇß½À´Ï´Ù.
  • À¯·´ Àå·ç °ü¸® ½ÃÀåÀº 2024³â 47.2%ÀÇ ¸ÅÃâ Á¡À¯À²·Î ¼¼°è ½ÃÀåÀ» Àå¾ÇÇß½À´Ï´Ù. ¿°Áõ¼º ÀåÁúȯ°ú ´ëÀå¾Ï ¹ßº´·üÀÇ Áõ°¡·Î Àå·ç ½Ã¼úÀÇ ºóµµ°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀº Àå·ç °ü¸®¿¡ ÇÊ¿äÇÑ Ã·´Ü ±â¼ú äÅÃ, ³ôÀº Àα¸ ±â¹Ý, Àå·ç °ü¸®¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Àå·ç °ü¸® ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå °èÅë Àü¸Á
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
  • ºñÁî´Ï½º ȯ°æ ºÐ¼®
    • ¾÷°è ºÐ¼® - Porter's Five Forces ºÐ¼®
    • PESTLE ºÐ¼®

Á¦4Àå Àå·ç °ü¸® ½ÃÀå : Á¦Ç° ºñÁî´Ï½º ºÐ¼®

  • Á¦Ç° ½ÃÀå Á¡À¯À², 2024³â ¹× 2030³â
  • Á¦Ç° ºÎ¹® ´ë½Ãº¸µå
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø ¹× µ¿Ç⠺м®, Á¦Ç°º°, 2018-2030³â
  • ¹ÐÆó ¹é
  • ¿ÀÇÂ/¹è¼ö ¹é
  • ¿øÇǽº ¹é
  • ÅõÇǽº ¹é
  • ±âŸ

Á¦5Àå Àå·ç °ü¸® ½ÃÀå : ¿ëµµ ºñÁî´Ï½º ºÐ¼®

  • ¿ëµµ ½ÃÀå Á¡À¯À², 2024³â ¹× 2030³â
  • ¿ëµµ ºÎ¹® ´ë½Ãº¸µå
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø ¹× µ¿Ç⠺м®, ¿ëµµº°, 2018-2030³â
  • °áÀå·ç
  • ȸÀå·ç
  • ¿ä·ç

Á¦6Àå Àå·ç °ü¸® ½ÃÀå : ÃÖÁ¾ ¿ëµµ ºñÁî´Ï½º ºÐ¼®

  • ÃÖÁ¾ ¿ëµµ ½ÃÀå Á¡À¯À², 2024³â ¹× 2030³â
  • ÃÖÁ¾ ¿ëµµ ºÎ¹® ´ë½Ãº¸µå
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø ¹× µ¿Ç⠺м®, ÃÖÁ¾ ¿ëµµº°, 2018-2030³â
  • ÀçÅà Äɾî ȯ°æ
  • º´¿ø
  • ±âŸ

Á¦7Àå Àå·ç °ü¸® ½ÃÀå : Á¦Ç°, ¿ëµµ, ÃÖÁ¾ ¿ëµµº° Áö¿ª ÃßÁ¤¡¤µ¿Ç⠺м®

  • Áö¿ªº° ½ÃÀå Á¡À¯À² ºÐ¼®, 2024³â ¹× 2030³â
  • Áö¿ª ½ÃÀå ´ë½Ãº¸µå
  • ½ÃÀå ±Ô¸ð, ¿¹Ãø µ¿Ç⠺м®, 2018-2030³â :
  • ºÏ¹Ì
    • ±¹°¡º°, 2018-2030³â
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • ±¹°¡º°, 2018-2030³â
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ³ë¸£¿þÀÌ
    • µ§¸¶Å©
    • ½º¿þµ§
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ±¹°¡º°, 2018-2030³â
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • ű¹
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ±¹°¡º°, 2018-2030³â
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ±¹°¡º°, 2018-2030³â
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • Äí¿þÀÌÆ®

Á¦8Àå °æÀï »óȲ

  • ÁøÃâ ±â¾÷ °³¿ä
  • ±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Ç ºÐ¼®
  • ±â¾÷ ºÐ·ù
  • Àü·« ¸ÅÇÎ
  • ±â¾÷ °³¿ä/»óÀå ±â¾÷
    • ALCARE Co., Ltd.
    • B. Braun Medical Inc.
    • Coloplast Group
    • Cymed
    • ConvaTec Group PLC
    • Hollister Incorporated
    • Marlen Manufacturing &Development Company
    • Nu-Hope Laboratories, Inc.
    • Perma-Type Company, Inc.
    • Salts Healthcare
    • Welland Medical Limited
    • Torbot Group, Inc.
ksm 24.11.25

Stoma Care Market Growth & Trends:

The global stoma care market size is anticipated to reach USD 873.2 million by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 6.4% from 2025 to 2030. Increasing cases of colorectal cancer, inflammatory bowel disease (IBD), increasing adoption of advanced technologies, and rising awareness regarding stoma care products are the key driving factors for the market.

Colorectal cancer is the most common cause of stomas, accounting for about 45.6% of all cases. More than 45.0% of colostomies are performed in ostomy patients aged 60 above, thereby surging the demand for healthcare products. In addition, colorectal cancer is the third most common form of cancer in both men and women. For instance, according to the report published by the World Health Organization (WHO), in 2020,9,35,000 deaths were reported out of 1.93 million cases due to colorectal cancer. Although it is more prevalent in adults aged 50 and older, however, the incidence rate has increased by 2.2% annually in individuals younger than 50 years.

For instance, according to the American Cancer Society, about 1.4 lakh individuals were diagnosed with colorectal cancer in 2020 of which 12.00% were individuals younger than 50. Furthermore, according to the National Center for Biotechnology Information (NCBI), colorectal cancer is the deadliest among males in UAE and deadliest among females in Japan. Therefore, such instances indicate a considerable increase in demand for healthcare products, as it is one of the essential requirements for treating such cases, thereby propelling market growth over the forecast period.

Stoma Care Market Report Highlights:

  • In terms of revenue, the others segment held the largest revenue share in 2024. The rising number of ostomies across the globe is the major factor propelling the segment growth
  • The colostomy segment held the largest revenue share in 2024 and is expected to witness a considerable growth rate over the forecast period due to the increasing prevalence of colon cancer
  • The home care settings segment held the largest revenue share in 2024. The segment growth is majorly driven by the outbreak of COVID-19 across the globe and the patients opting for homecare services
  • Europe stoma care market dominated the global market with a revenue share of 47.2% in 2024. The increasing incidence of inflammatory bowel diseases and colorectal cancer is driving the frequency of ostomy procedures.
  • In Asia Pacific, the market is anticipated to witness the fastest growth rate over the forecast period due to the adoption of advanced technologies required for stoma care, high population base, and rising awareness about ostomy care

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Stoma Care Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Stoma Care Market: Product Business Analysis

  • 4.1. Product Market Share, 2024 & 2030
  • 4.2. Product Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Closed Bags
    • 4.4.1. Closed Bags Market, 2018 - 2030 (USD Million)
  • 4.5. Open/Drainable Bags
    • 4.5.1. Open/Drainable Bags Market, 2018 - 2030 (USD Million)
  • 4.6. One-piece Bags
    • 4.6.1. One-piece Bags Market, 2018 - 2030 (USD Million)
  • 4.7. Two-piece Bags
    • 4.7.1. Two-piece Bags Market, 2018 - 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Stoma Care Market: Application Business Analysis

  • 5.1. Application Market Share, 2024 & 2030
  • 5.2. Application Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Colostomy
    • 5.4.1. Colostomy Market, 2018 - 2030 (USD Million)
  • 5.5. Ileostomy
    • 5.5.1. Ileostomy Market, 2018 - 2030 (USD Million)
  • 5.6. Urostomy
    • 5.6.1. Urostomy Market, 2018 - 2030 (USD Million)

Chapter 6. Stoma Care Market: End Use Business Analysis

  • 6.1. End Use Market Share, 2024 & 2030
  • 6.2. End Use Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Home Care Settings
    • 6.4.1. Home Care Settings Market, 2018 - 2030 (USD Million)
  • 6.5. Hospitals
    • 6.5.1. Hospitals Market, 2018 - 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Stoma Care Market: Regional Estimates & Trend Analysis by Product, Application, and End Use

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America Stoma Care Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework
      • 7.4.2.3. Competitive Insights
      • 7.4.2.4. U.S. Stoma Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework
      • 7.4.3.3. Competitive Insights
      • 7.4.3.4. Canada Stoma Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Regulatory Framework
      • 7.4.4.3. Competitive Insights
      • 7.4.4.4. Mexico Stoma Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Stoma Care Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework
      • 7.5.2.3. Competitive Insights
      • 7.5.2.4. UK Stoma Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework
      • 7.5.3.3. Competitive Insights
      • 7.5.3.4. Germany Stoma Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework
      • 7.5.4.3. Competitive Insights
      • 7.5.4.4. France Stoma Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework
      • 7.5.5.3. Competitive Insights
      • 7.5.5.4. Italy Stoma Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework
      • 7.5.6.3. Competitive Insights
      • 7.5.6.4. Spain Stoma Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Norway
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework
      • 7.5.7.3. Competitive Insights
      • 7.5.7.4. Norway Stoma Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework
      • 7.5.8.3. Competitive Insights
      • 7.5.8.4. Denmark Stoma Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Sweden
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Regulatory Framework
      • 7.5.9.3. Competitive Insights
      • 7.5.9.4. Sweden Stoma Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Stoma Care Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework
      • 7.6.2.3. Competitive Insights
      • 7.6.2.4. Japan Stoma Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework
      • 7.6.3.3. Competitive Insights
      • 7.6.3.4. China Stoma Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework
      • 7.6.4.3. Competitive Insights
      • 7.6.4.4. India Stoma Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework
      • 7.6.5.3. Competitive Insights
      • 7.6.5.4. South Korea Stoma Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework
      • 7.6.6.3. Competitive Insights
      • 7.6.6.4. Australia Stoma Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Regulatory Framework
      • 7.6.7.3. Competitive Insights
      • 7.6.7.4. Thailand Stoma Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Stoma Care Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework
      • 7.7.2.3. Competitive Insights
      • 7.7.2.4. Brazil Stoma Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Framework
      • 7.7.3.3. Competitive Insights
      • 7.7.3.4. Argentina Stoma Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA Stoma Care Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework
      • 7.8.2.3. Competitive Insights
      • 7.8.2.4. South Africa Stoma Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework
      • 7.8.3.3. Competitive Insights
      • 7.8.3.4. Saudi Arabia Stoma Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework
      • 7.8.4.3. Competitive Insights
      • 7.8.4.4. UAE Stoma Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Regulatory Framework
      • 7.8.5.3. Competitive Insights
      • 7.8.5.4. Kuwait Stoma Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. ALCARE Co., Ltd.
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. B. Braun Medical Inc.
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Coloplast Group
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Cymed
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. ConvaTec Group PLC
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Hollister Incorporated
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Marlen Manufacturing & Development Company
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Nu-Hope Laboratories, Inc.
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. Perma-Type Company, Inc.
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Salts Healthcare
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives
    • 8.5.11. Welland Medical Limited
      • 8.5.11.1. Overview
      • 8.5.11.2. Financial Performance
      • 8.5.11.3. Product Benchmarking
      • 8.5.11.4. Strategic Initiatives
    • 8.5.12. Torbot Group, Inc.
      • 8.5.12.1. Overview
      • 8.5.12.2. Financial Performance
      • 8.5.12.3. Product Benchmarking
      • 8.5.12.4. Strategic Initiatives
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦